| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 01/14/2010 | US20100009995 Maleate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-oxo-6,7-dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 01/14/2010 | US20100009994 L-Malate Salts of 6-(5-Chloro-2-Pyridyl)-5-[(4-Methyl-1-Piperazinyl)Carbonyloxy]-7-Oxo-6,7-Dihydro-5H-Pyrrolo[3,4-b]Pyrazine |
| 01/14/2010 | US20100009963 Kinase antagonists |
| 01/14/2010 | US20100009959 Pentacyclic Indole Derivatives as Antiviral Agents |
| 01/14/2010 | US20100009958 Quinazoline derivatives |
| 01/14/2010 | US20100009214 Alpha-diketopyrrolopyrrole pigment, coloring composition containing the same, and red film |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | CA2730319A1 Tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730314A1 Bicyclic compounds having antimitotic and/or antitumor activity and methods of use thereof |
| 01/14/2010 | CA2730280A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 01/14/2010 | CA2730106A1 Kinase inhibitors and methods of use |
| 01/14/2010 | CA2728213A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors |
| 01/13/2010 | EP2143727A1 Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors |
| 01/13/2010 | EP2143724A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 01/13/2010 | EP2142552A1 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 01/13/2010 | EP2142551A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| 01/13/2010 | EP1660095B1 Tricyclic parp inhibitors |
| 01/13/2010 | EP1422229B1 Porphyrin-metal complexes and oxygen infusions containing the same |
| 01/13/2010 | EP0723548B1 Phosphorescent compounds for imaging tissue oxygen |
| 01/13/2010 | CN101627042A Substituted piperidines containing a heteroarylamide or heteroarylphenyl moiety |
| 01/13/2010 | CN101627041A Process and intermediates for the synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro- pyrazolo[1,5-a]pyrimidin-7-yl)-amino derivatives and intermediates |
| 01/13/2010 | CN101624395A Synthetic method of hexabenzylhexaazaisowurtzitane |
| 01/13/2010 | CN101624394A Sphericized hexanitrohexaazaisowurtzitane (HNIW) crystal and preparation method thereof |
| 01/13/2010 | CN100579976C P38 inhibitors and methods of use thereof |
| 01/12/2010 | US7645788 Treating breast cancer cells which are both estrogen-dependent and estrogen-negative; chemical systhesis by reacting indole-3-carbinol with an oxidizing agent in a solvent, cyclization, purification |
| 01/12/2010 | US7645764 Kinase inhibitors and methods for using the same |
| 01/12/2010 | US7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors |
| 01/12/2010 | US7645761 Indoline derivatives |
| 01/12/2010 | US7645756 Nitrogenous fused heteroaromatic ring derivative |
| 01/12/2010 | US7645754 Pyrrolopyrimidine A2B selective antagonist compounds, their synthesis and use |
| 01/12/2010 | CA2192089C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/07/2010 | WO2010002954A1 (2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/07/2010 | WO2010002820A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers |
| 01/07/2010 | WO2010002472A1 Jak kinase modulating compounds and methods of use thereof |
| 01/07/2010 | WO2010001869A1 Tetra-substituted benzene compound and use thereof |
| 01/07/2010 | WO2010000978A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | WO2010000834A1 Use of ionic liquids as catalysts |
| 01/07/2010 | WO2010000469A2 Crystalline salts of sitagliptin |
| 01/07/2010 | WO2010000031A1 Imidazopyrimidinones and uses thereof |
| 01/07/2010 | WO2009143024A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/07/2010 | WO2009140128A3 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors |
| 01/07/2010 | WO2009138796A3 Imidazo [2,1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents |
| 01/07/2010 | WO2009121063A3 Chemokine receptor modulators |
| 01/07/2010 | US20100004444 Novel Triazolo pyrimidine compounds |
| 01/07/2010 | US20100004269 5-anilinoimidazopyridines and methods of use |
| 01/07/2010 | US20100004252 Substituted tetrahydropyrrolopyrazine compounds and the use thereof in the treatment and/or inhibition of pain |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004239 Pyrrolo [3,2-C] Pyridine-4-One 2-Indolinone Protein Kinase Inhibitors |
| 01/07/2010 | US20100004238 Fused heterocyclic compound |
| 01/07/2010 | US20100004226 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects |
| 01/07/2010 | US20100004218 Bridged polycyclic compound based compositions for renal therapy |
| 01/07/2010 | US20100004207 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto |
| 01/07/2010 | US20100003250 (2-aryl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)morpholine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | CA2729696A1 Crystalline salts of sitagliptin |
| 01/07/2010 | CA2729690A1 Novel pyrrolo [2,3-a] carbazoles and use thereof as pim kinase inhibitors |
| 01/07/2010 | CA2729656A1 Imidazopyrimidinones and uses thereof |
| 01/07/2010 | CA2729552A1 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/07/2010 | CA2728559A1 Cdk modulators |
| 01/06/2010 | EP2139896A1 Pyrimido [4, 5-d]azepine derivatives as 5-ht2c agonists |
| 01/06/2010 | EP2139869A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders |
| 01/06/2010 | EP2139490A2 Diazo bicyclic smac mimetics and the uses thereof |
| 01/06/2010 | EP2139329A1 Novel imidazo based heterocycles |
| 01/06/2010 | CN101622257A Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 01/06/2010 | CN101619064A Synthesis and process method for novel polynitrogen heterocycle pharmaceutical intermediates |
| 01/06/2010 | CN100577663C Fused heterocyclic kinase inhibitors |
| 01/06/2010 | CN100577651C Lactam compound and medicinal use thereof |
| 01/06/2010 | CN100577167C Use of pyridazino[4,5-b]indole-1-acetamide derivatives for preparing medicines for treating disease related to dysfunction of peripheral benzodiazepin receptors |
| 01/05/2010 | US7642360 Composition for dyeing keratinous fibers comprising at least one diamino-N,N-dihydropyrazolone derivative |
| 01/05/2010 | US7642266 cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 01/05/2010 | US7642265 Benzimidazoles and analogs thereof as antivirals |
| 01/05/2010 | US7642257 Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors |
| 01/05/2010 | US7642255 Compounds and compositions as protein kinase inhibitors |
| 01/05/2010 | CA2545999C 1,2-di(cyclic)substituted benzene compounds |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326241 PROCESS FOR PREPARING SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINES |
| 12/31/2009 | US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents |
| 12/31/2009 | US20090326028 Process for the preparation of temozolomide and analogs |
| 12/31/2009 | US20090326015 Compounds with embedded benzopyran motif for core structures and preparation method thereof |
| 12/31/2009 | US20090325986 Deazapurine Analogs of 1'-Aza-L-Nucleosides |
| 12/31/2009 | US20090325970 Aza-indoles and related compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 12/31/2009 | US20090325968 Compositions Useful as Inhibitors of Protein Kinases |
| 12/31/2009 | US20090325955 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325939 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 12/31/2009 | US20090325937 Pyridazine Compounds as Glycogen Synthase Kinase 3 Inhibitors |
| 12/31/2009 | US20090325935 Gyrase inhibitors and uses thereof |
| 12/31/2009 | US20090325929 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof |
| 12/31/2009 | US20090325928 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors |
| 12/31/2009 | US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158394A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents |
| 12/30/2009 | WO2009158369A1 Synthesis and use of heterocyclic antibacterial agents |
| 12/30/2009 | WO2009158011A1 Alkynyl alcohols as kinase inhibitors |
| 12/30/2009 | WO2009157423A1 Oxazolidinone derivative having fused ring |
| 12/30/2009 | WO2009157196A1 Amide compound |
| 12/30/2009 | WO2009156951A2 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds |